Latest News

Polycystic Ovary Syndrome Associated With Midlife Memory, Thinking Problems


 

TOPLINE:

People with polycystic ovary syndrome (PCOS) may score lower on cognitive tests than people without the condition, a research showed. They also may have worse integrity of brain tissue as evident on an MRI.

METHODOLOGY:

  • Researchers used data from the Coronary Artery Risk Development in Young Adults Women’s Study; individuals were 18-30 years old at the beginning of the study and were followed over 30 years.
  • A little over 900 women were included in the study, of which 66 had PCOS, which was defined as having elevated androgen levels or self-reported hirsutism and irregular menstrual cycles more than 32 days apart.
  • Study participants completed tests measuring verbal learning and memory, processing speed and executive function, attention and cognitive control, and semantics and attention.
  • Researchers analyzed brain white matter integrity for 291 of the individuals, including 25 with PCOS, who underwent MRI.

TAKEAWAY:

  • Individuals with PCOS had worse memory, attention, and verbal ability scores than those without the disorder.
  • MRI scans showed that those with PCOS had lower white matter integrity, an indicator of cognitive deficits, including poorer decision-making abilities.
  • Those in the PCOS group were more likely to be White and have diabetes than those in the control group.

IN PRACTICE:

“This report of midlife cognition in PCOS raises a new concern about another potential comorbidity for individuals with this common disorder; given that up to 10% of women may be affected by PCOS, these results have important implications for public health at large,” the authors concluded.

SOURCE:

Heather G. Huddleston, MD, director of the PCOS Clinic at the UCSF Health, San Francisco, California, is the lead author of the study published in Neurology.

LIMITATIONS:

PCOS was determined on the basis of serum androgen levels and self-reporting of hirsutism and oligomenorrhea, so some cases may have been misclassified without the official diagnosis of a clinician.

DISCLOSURES:

The authors did not report any relevant financial conflicts. The study was funded by a grant from the University of California, San Francisco, California.

A version of this article appeared on Medscape.com.

Recommended Reading

How physicians can provide better care to transgender patients
MDedge Psychiatry
Drug effective in treating symptoms of postpartum depression
MDedge Psychiatry
Sexual assault in women tied to increased stroke, dementia risk
MDedge Psychiatry
Steroid a promising short-term treatment option for major depression?
MDedge Psychiatry
Alabama cites Roe decision in call to ban transgender health care
MDedge Psychiatry
Postpartum depression risk higher with family psych history
MDedge Psychiatry
Neuropsychiatric side effects of hormonal contraceptives: More common than you think!
MDedge Psychiatry
Oxycodone tied to persistent use only after vaginal delivery
MDedge Psychiatry
Bipolar disorder may raise risk of polycystic ovarian syndrome
MDedge Psychiatry
Restricted Abortion Access Tied to Mental Health Harm
MDedge Psychiatry